Epidemiology of Sjögren syndrome

M Beydon, S McCoy, Y Nguyen, T Sumida… - Nature Reviews …, 2024 - nature.com
Sjögren syndrome is a phenotypically varied autoimmune disorder that can occur alone in
primary Sjögren syndrome or in association with other connective tissue diseases (CTDs) …

[PDF][PDF] One year in review 2021: systemic vasculitis

F Ferro, L Quartuccio, S Monti, P Delvino… - Clin Exp …, 2021 - clinexprheumatol.org
Large-and small-vessel vasculitis are complex potentially life-threatening systemic
autoimmune diseases that have recently been subjected to considerable immunologic and …

Clinical picture, outcome and predictive factors of lymphoma in primary Sjögren's syndrome: results from a harmonized dataset (1981–2021)

LG Chatzis, IE Stergiou, AV Goules, V Pezoulas… - …, 2022 - academic.oup.com
Abstract Objectives Primary Sjögren's Syndrome (pSS) carries the highest risk for non-
Hodgkin's lymphoma (NHL) development among systemic autoimmune diseases. However …

A biomarker for lymphoma development in Sjogren's syndrome: salivary gland focus score

L Chatzis, AV Goules, V Pezoulas, C Baldini… - Journal of …, 2021 - Elsevier
The aim of this study is to explore the role of labial minor salivary gland (LMSG) focus score
(FS) in stratifying Sjögren's Syndrome (SS) patients, lymphoma development prediction and …

Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies

G Hernández-Molina, B Kostov, P Brito-Zerón… - …, 2023 - academic.oup.com
Objective To characterize 414 patients with primary SS who developed haematological
malignancies and to analyse how the main SS-and lymphoma-related features can modify …

Influence of the age at diagnosis in the disease expression of primary Sjögren syndrome. Analysis of 12,753 patients from the Sjögren Big Data Consortium

S Retamozo, N Acar-Denizli, IF Horváth… - Clinical and …, 2021 - discovery.ucl.ac.uk
OBJECTIVE: To analyse how the main components of the disease phenotype (sicca
symptoms, diagnostic tests, immunological markers and systemic disease) can be driven by …

Sjögren syndrome: looking forward to the future

S Zandonella Callegher, I Giovannini… - Therapeutic …, 2022 - journals.sagepub.com
Primary Sjögren's syndrome (pSS) is a heterogeneous disease characterised by a wide
spectrum of manifestations that vary according to the different stages of the disease and …

Management of Sjögren's syndrome: present issues and future perspectives

C Vitali, A Minniti, F Pignataro, W Maglione… - Frontiers in …, 2021 - frontiersin.org
In view of the new possibilities for the treatment of primary Sjögren's syndrome (pSS) given
by the availability of new biotechnological agents targeting the various molecular and …

[PDF][PDF] One year in review 2021: Sjögren's syndrome

G Cafaro, R Bursi, LG Chatzis, G Fulvio… - Clin Exp …, 2021 - clinexprheumatol.org
Sjögren's syndrome (SS) is a multifactorial systemic autoimmune disease of unknown
aetiology characterised by a wide spectrum of different clinical manifestations and scattered …

[HTML][HTML] Addressing the clinical unmet needs in primary Sjögren's Syndrome through the sharing, harmonization and federated analysis of 21 European cohorts

VC Pezoulas, A Goules, F Kalatzis, L Chatzis… - Computational and …, 2022 - Elsevier
For many decades, the clinical unmet needs of primary Sjögren's Syndrome (pSS) have
been left unresolved due to the rareness of the disease and the complexity of the underlying …